Lumida
/WVE
⌘K
WAVE Life Sciences Ltd

WAVE Life Sciences Ltd

WVE
$4.59USD-1.71%-0.08 today

MARKET CAP

904.5M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$5
$22

AI Summary

Stalk
TrimMedium

In a Stage 4 decline, WVE remains under sustained seller control with price below all key EMAs and forming sequential lower highs and lower lows. Despite extreme oversold readings and a bearish exhaustion signal, no stable base has formed, and rallies continue to stall on muted volume. The medium-term bias is bearish, and sellers should defer new execution until rallies into resistance rather than selling into diminishing downside momentum.

  • WVE-007 achieved placebo-adjusted 4% total fat and 9.2% visceral reduction at 240 mg dose over three months.
  • Proprietary RNAi/editing technology targets inhibin E, preserving lean mass versus GLP-1 therapies.
  • Q2 2026 net loss rose to $69.4 M from $50.5 M YoY, with R&D up to $51.3 M.
Full analysis →

Buying

10

institutions

Selling

5

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY19.20 M111.57 M+5.09 M+9.0%0.00%
MM

Millennium Management LLC

Q2 2026

BUY1.81 M10.52 M+839.04 K+49.3%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUY1.70 M9.90 M+1.11 M+128.7%0.01%
AC

Aqr Capital Management LLC

Q2 2026

BUY1.65 M9.58 M+1.20 M+192.7%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY1.49 M8.64 M+1.45 M+3157.6%0.01%
CA

Citadel Advisors LLC

Q2 2026

SELL618.75 K3.59 M+-2.20 M-82.4%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL618.17 K3.55 M+-52.00 K-20.1%0.00%
MG

Man Group Plc

Q2 2026

BUY505.46 K2.94 M+441.42 K+532.5%0.00%
WP

Woodline Partners LP

Q2 2026

SELL350.53 K2.04 M+-350.53 K-59.9%0.01%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY160.00 K929.60 K+115.10 K+185.6%0.04%
JH

Janus Henderson Group Plc

Q1 2026

BUY103.40 K749.13 K+51.70 K-14.6%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW60.88 K353.74 K+60.88 K+0.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY2.34 K13.60 K+74.00-17.2%0.00%
VI

Voloridge Investment Management, LLC

Q2 2026

SELL0.000.00+-288.50 K-100.0%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL0.000.00+-211.07 K-100.0%0.00%